Therefore, engagement of IFNGR on distinct tumor stromal cells, induction of ISGs, immune status of the TME, and IFN-γ concentration are recognized as critical determinants for IFN-γ-mediated outcomes. This evidence concerns the gene IFNG and neoplasm.